When cancer subtypes were examined, the analysis revealed that phototherapy was linked to a 40% increased odds of blood cancers. More modest associations were observed for solid organ cancers and ...
J&J's phase IIb JASMINE study on nipocalimab meets key endpoints in systemic lupus erythematosus, supporting plans to advance ...
According to DelveInsight’s latest analysis, Nipocalimab is expected to capture meaningful market share across both prevalent ...
Johnson & Johnson today announced positive topline results from the Phase 2b JASMINE (NCT04882878) study of adults living with systemic lupus erythematosus (SLE) and the initiation of a Phase 3 ...
Zacks.com on MSN
Can J&J's Pipeline Progress in 2025 Aid Long-Term Growth?
Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.
Though a child's HDFN diagnosis is in no way their parent's fault, it is normal to have feelings of guilt after they are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback